Alendronate Sodium
NDC 50090-1802
Product Information
Alendronate Sodium is a ANDA-approved product labeled by A-s Medication Solutions. Alendronate is used to prevent and treat certain types of bone loss (osteoporosis) in adults. It is supplied as a white product. This product entry covers the primary NDC 50090-1802 and 2 associated package configurations. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
638
Code Structure Chart
Product Details
What is NDC 50090-1802?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- ALENDRONATE SODIUM (UNII: 2UY4M2U3RA)
- ALENDRONIC ACID (UNII: X1J18R4W8P) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)
- STARCH, CORN (UNII: O8232NY3SJ)
- SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 904396 - alendronate sodium 35 MG Oral Tablet
- RxCUI: 904396 - alendronic acid 35 MG Oral Tablet
- RxCUI: 904396 - alendronic acid 35 MG (as alendronate sodium 45.7 MG) Oral Tablet
- RxCUI: 904431 - alendronate sodium 70 MG Oral Tablet
- RxCUI: 904431 - alendronic acid 70 MG Oral Tablet
* Please review the full disclaimer at the bottom of this page.